InvestorsHub Logo
Followers 5
Posts 859
Boards Moderated 0
Alias Born 07/27/2010

Re: dangerx post# 801

Monday, 12/22/2014 9:32:21 AM

Monday, December 22, 2014 9:32:21 AM

Post# of 3723
Hey dangerx,

Yeah, this is what i was referencing for the timing of the phase 3 trials:

"This collaboration is aligned with Palatin's global strategy to bring bremelanotide to the market for the millions of women who have female sexual dysfunction and are seeking a safe and effective treatment." Dr. Spana further stated that, "In addition, we are focused on starting the bremelanotide phase 3 clinical trials in the U.S. in the fourth quarter of 2014 and on furthering discussions for partnerships for the U.S. and other territories."

finance.yahoo.com/news/palatin-technologies-licenses-bremelanotide-europe-060000599.html

So, it looks like that's not going to happen if I had to guess.

9 day count down...



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News